TVARDI THERAPEUTICS, INC. Deferred Tax Assets, Operating Loss Carryforwards
TVARDI THERAPEUTICS, INC. (TVRD) had Deferred Tax Assets, Operating Loss Carryforwards of $122.73 million as of 2024-12-31, per its 10-K filed 2025-03-11.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2025-03-11
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $122.73M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $123.74M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $113.06M.
- 2021-12-31: Deferred Tax Assets, Operating Loss Carryforwards $113.64M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2024-12-31 | $122.73M 10-K · filed 2025-03-11 |
| 2023-12-31 | $123.74M 10-K · filed 2025-03-11 |
| 2022-12-31 | $113.06M 10-K · filed 2024-03-06 |
| 2021-12-31 | $113.64M 10-K · filed 2023-03-06 |
| 2020-12-31 | $93.51M 10-K · filed 2022-03-01 |
| 2019-12-31 | $84.61M 10-K · filed 2021-02-25 |
| 2018-12-31 | $73.58M 10-K · filed 2020-02-27 |
| 2017-12-31 | $54.83M 10-K · filed 2019-03-12 |
| 2016-12-31 | $57.89M 10-K · filed 2018-03-15 |
| 2015-12-31 | $36.22M 10-K · filed 2017-03-10 |
| 2014-12-31 | $27.09M 10-K · filed 2016-03-11 |
| 2013-12-31 | $21.43M 10-K · filed 2015-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |